Upstream Bio (UPB) Non Operating Income (2023 - 2026)

Upstream Bio's Non Operating Income history runs 4 years deep, the most recent figure standing at $3.0 million for Q1 2026.

• In Q1 2026, Non Operating Income changed N/A year-over-year to $3.0 million; the TTM figure through Mar 2026 stood at -$1.7 million (down 116.0% YoY), while the FY2025 annual figure was -$15000.0, down 100.1% from the prior year.
• Non Operating Income for Q1 2026 stood at $3.0 million, up from -$13.2 million in the prior quarter.
• The five-year high for Non Operating Income was $19.7 million in Q4 2023, with the low at -$13.2 million in Q4 2025.
• The 4-year median for Non Operating Income is $4.1 million (2024), against an average of $3.9 million.
• Peak annual rise in Non Operating Income reached 53.07% in 2025, while the deepest fall reached 360.54% in 2025.
• Upstream Bio's Non Operating Income stood at $19.7 million in 2023, then tumbled by 74.21% to $5.1 million in 2024, then sank by 360.54% to -$13.2 million in 2025, then soared by 122.87% to $3.0 million in 2026.
• Business Quant data shows UPB's Non Operating Income at $3.0 million in Q1 2026, -$13.2 million in Q4 2025, and $4.1 million in Q3 2025.